We are live on ! Find out more
CPA

Capital Performance Advisors Portfolio holdings

AUM $1.5B
1-Year Est. Return 21.4%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+21.4%
3 Year Est. Return
+61.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$329M
AUM Growth
+$65.6M
Cap. Flow
+$47.9M
Cap. Flow %
14.56%
Top 10 Hldgs %
61.59%
Holding
2,901
New
2,799
Increased
53
Reduced
27
Closed
2

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$772K
2
NVDA icon
NVIDIA
NVDA
+$662K
3
AAPL icon
Apple
AAPL
+$589K
4
MSFT icon
Microsoft
MSFT
+$568K
5
AVGO icon
Broadcom
AVGO
+$431K

Top Sells

Rank Stock Value
1
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$521K
2
DFAT icon
Dimensional US Targeted Value ETF
DFAT
+$503K
3
DCOR icon
Dimensional US Core Equity 1 ETF
DCOR
+$497K
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$488K
5
DFIV icon
Dimensional International Value ETF
DFIV
+$447K

Sector Composition

Rank Sector Weight
1 Technology 10.08%
2 Financials 4.66%
3 Consumer Discretionary 2.92%
4 Healthcare 2.04%
5 Industrials 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRON icon
2701
Disc Medicine
IRON
$2.87B
$98 ﹤0.01%
+2
New +$94
ADV icon
2702
Advantage Solutions
ADV
$494M
$96 ﹤0.01%
+1
New +$92
LXU icon
2703
LSB Industries
LXU
$830M
$96 ﹤0.01%
+12
New +$95
SWTX
2704
DELISTED
SpringWorks Therapeutics
SWTX
$96 ﹤0.01%
+3
New +$112
VSAT icon
2705
Viasat
VSAT
$10.2B
$96 ﹤0.01%
+8
New +$129
ONIT
2706
Onity Group
ONIT
$339M
$96 ﹤0.01%
+3
New +$82
LOB icon
2707
Live Oak Bancshares
LOB
$1.95B
$95 ﹤0.01%
+2
New +$84
VERU icon
2708
Veru
VERU
$37.4M
$95 ﹤0.01%
+12
New +$104
VYGR icon
2709
Voyager Therapeutics
VYGR
$186M
$94 ﹤0.01%
+16
New +$116
ALV icon
2710
Autoliv
ALV
$8.75B
$93 ﹤0.01%
+1
New +$100
SOUN icon
2711
SoundHound AI
SOUN
$2.8B
$93 ﹤0.01%
+20
New +$97
AEVA
2712
Aeva Technologies
AEVA
$1.06B
$92 ﹤0.01%
+28
New +$84
ALDX icon
2713
Aldeyra Therapeutics
ALDX
$94.7M
$92 ﹤0.01%
+17
New +$81
NRC icon
2714
NRC Health Common Stock
NRC
$479M
$91 ﹤0.01%
+4
New +$90
AKBA icon
2715
Akebia Therapeutics
AKBA
$341M
$90 ﹤0.01%
+68
New +$91
BLUE
2716
DELISTED
bluebird bio
BLUE
$90 ﹤0.01%
+9
New +$150
RICK icon
2717
RCI Hospitality Holdings
RICK
$202M
$89 ﹤0.01%
+2
New +$90
WST icon
2718
West Pharmaceutical
WST
$23.4B
– –
0
– –
STXS icon
2719
Stereotaxis
STXS
$132M
$88 ﹤0.01%
+43
New +$87
TCMD icon
2720
Tactile Systems Technology
TCMD
$625M
$88 ﹤0.01%
+6
New +$78
IVVD icon
2721
Invivyd
IVVD
$183M
$87 ﹤0.01%
+85
New +$92
JBGS
2722
JBG SMITH
JBGS
$832M
$87 ﹤0.01%
+5
New +$85
ARHS icon
2723
Arhaus
ARHS
$1.13B
$86 ﹤0.01%
+7
New +$95
IMVT icon
2724
Immunovant
IMVT
$8.35B
$86 ﹤0.01%
+3
New +$88
NKTR icon
2725
Nektar Therapeutics
NKTR
$2.38B
$86 ﹤0.01%
+4
New +$76
107 108
109
110 111

Similar funds

SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Capital Performance Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Capital Performance Advisors held 2,901 positions worth $329M, up 25% from $263M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Capital Performance Advisors deployed $47.9M of net new capital in Q3 2024, opening 2,799 new positions and adding to 53 existing holdings. Its largest new stake was Broadcom: 2,686 shares worth $463K.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $521K trimmed.

  • Capital Performance Advisors's largest Q3 2024 buy was Broadcom: 2,686 shares worth $463K.
  • Capital Performance Advisors added most to Amazon in Q3 2024, an estimated $772K increase.
  • Capital Performance Advisors's biggest Q3 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $521K.
  • Capital Performance Advisors fully exited Dimensional US Core Equity 1 ETF in Q3 2024, selling an estimated $497K.
  • Capital Performance Advisors's ten largest holdings make up 62% of its $329M portfolio in Q3 2024.
  • Capital Performance Advisors opened 2,799 new positions and closed 2 in Q3 2024.
  • Capital Performance Advisors's portfolio value rose 25% quarter-over-quarter to $329M.

Based on Capital Performance Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.